Skip to main content
logo
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.340
-0.090 (-2.03%)
Aug 12, 2026, 3:44 PM EDT - Market open

IMDX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
140215422138200
Market Cap Growth
90.67%417.89%101.13%-45.77%-80.97%21.16%
Enterprise Value
125.01207.0436.5719.2226.5171.97
Last Close Price
4.347.502.382.506.4243.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
83.1453.0522.0813.7439.7591.06
PB Ratio
--6.84-3.381.011.113.07

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
74.0851.0619.4412.7827.6778.24

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.04-0.05-0.190.090.070.07
Net Debt / Equity Ratio
0.710.260.41-0.32-0.49-0.43
Net Debt / EBITDA Ratio
0.320.170.080.281.320.57
Net Debt / FCF Ratio
0.490.320.230.280.340.74
Asset Turnover
0.060.130.030.020.010.02
Inventory Turnover
2.644.115.57---
Quick Ratio
1.741.051.411.381.852.50
Current Ratio
2.001.271.621.492.112.77
Return on Equity (ROE)
187.10%229.65%-910.86%-85.23%-139.11%-129.88%
Return on Assets (ROA)
-182.24%-168.07%-111.01%-28.73%-13.86%-45.18%
Return on Invested Capital (ROIC)
-211.43%-246.46%-260.65%-120.43%-60.24%-136.16%
Return on Capital Employed (ROCE)
-306.34%-246.46%-127.83%-32.29%-15.42%-56.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-52.44%-133.16%-70.84%-38.10%-24.61%-35.80%
Total Shareholder Return
-52.44%-133.16%-70.84%-38.10%-24.61%-35.80%
SEC Filings: 10-K · 10-Q